Epithalon, also spelled Epitalon and referred to in the primary literature by its sequence, Ala-Glu-Asp-Gly (AEDG), is a synthetic tetrapeptide developed by Vladimir Khavinson's research group as a shorter, stable analog of a natural regulatory peptide isolated from pineal gland tissue. It belongs to a family of short synthetic peptides, sometimes called bioregulator peptides, that Khavinson and colleagues have studied across various organ-specific tissue extracts. Epithalon is the most extensively published member of that family in the specific areas of telomerase activity in cultured human cells and biomarkers of aging in rodent models, which is why it is often discussed alongside pineal and endocrine physiology in the research literature.
| Attribute | Detail |
|---|---|
| Name | Epithalon (Epitalon), sequence Ala-Glu-Asp-Gly (AEDG) |
| Class | Synthetic tetrapeptide, member of the Khavinson bioregulator peptide family |
| Sequence length | 4 amino acids |
| Origin | Modeled on a peptide fraction isolated from pineal gland (epiphysis) tissue extract |
| What studies examine | Telomerase activity and replicative capacity in cultured human somatic cells, biomarkers of aging and tumor incidence in rodent models, retinal and pineal tissue effects in rats |
| Form supplied | Lyophilized powder, research use only |
What is the chemical structure of Epithalon?
Epithalon is a linear tetrapeptide built from four standard amino acids in sequence: alanine, glutamate, aspartate and glycine, abbreviated AEDG. It is a fully synthetic molecule designed to reproduce the activity researchers attributed to a naturally occurring peptide fraction extracted from pineal gland tissue, part of a broader research program cataloged in Khavinson's 2021 systematic review of peptide regulation of gene expression. As a four-residue peptide, Epithalon is structurally simple compared with most of the other research peptides in this category, closer in scale to KPV than to larger growth-factor peptides.
What have human cell line studies examined?
The most cited line of Epithalon research concerns telomerase, the enzyme that maintains the protective repeat sequences (telomeres) at the ends of chromosomes and whose activity is limited in most differentiated human somatic cells. Khavinson et al. (2003) reported that Epithalon induced telomerase activity and telomere elongation in a human somatic cell line, using telomerase activity assays and telomere length measurement to track the effect over successive cell divisions. A related 2004 paper from the same group examined the Hayflick limit, the finite number of divisions a normal human somatic cell line undergoes before entering senescence, and reported that Epithalon treatment was associated with an increased number of population doublings before that limit was reached in the cultured cells studied. Together these cell-culture papers form the basis for describing Epithalon as a tool for studying telomerase regulation in vitro rather than a general growth-promoting peptide.
What have rodent aging and tumor-incidence studies examined?
Rodent studies of Epithalon have focused on biomarkers of aging and, in some cases, spontaneous tumor incidence over the animal's natural lifespan. Anisimov et al. (2003) studied Epithalon in female Swiss-derived SHR mice, tracking biomarkers of biological age, overall lifespan and the rate of spontaneous tumor development across the animals' full lifespan in a long-term rodent study. This is a laboratory model of aging in animals, not a clinical study in humans, and the compound was not administered as part of any prescribed human or veterinary treatment protocol. Separately, Khavinson et al. (2003) examined Epithalon's effect on retinal and pigmented epithelial cell proliferation in rats of varying ages, reporting a retinoprotective effect that the authors linked to the peptide's influence on cell proliferation in aging retinal tissue.
What is the proposed mechanism behind Epithalon's activity?
Khavinson's broader research program, summarized in the 2021 systematic review of peptide regulation of gene expression, proposes that short regulatory peptides like Epithalon act at the level of gene transcription, potentially by interacting with regulatory regions of DNA to influence expression of specific genes, including genes involved in telomerase regulation. A 2025 overview in the International Journal of Molecular Sciences (Araj et al.) summarizes this mechanistic literature alongside the cell and animal findings described above, situating Epithalon within the larger question of how short peptide sequences might influence gene expression programs associated with cellular aging.
How does Epithalon relate to other bioregulator peptides?
Epithalon is one member of a family of tissue-specific short peptides that Khavinson's group has characterized, alongside compounds such as Thymalin and Pinealon that are modeled on other organ tissue extracts. How these bioregulator peptides compare in composition and proposed tissue specificity is covered in bioregulator peptides explained, which also discusses Pinealon and Thymalin specifically; lot pages for those related research peptides are available at Pinealon and Thymalin. Each member of this peptide family is typically described in the literature by the tissue extract it was modeled on rather than by a shared structural motif, since the sequences themselves differ considerably between family members; Epithalon and Pinealon both trace to pineal tissue work, while Thymalin traces to thymic tissue extracts studied separately by the same research group.
Frequently asked questions
What does the name Epithalon refer to?
Epithalon, also spelled Epitalon, refers to the synthetic tetrapeptide Ala-Glu-Asp-Gly (AEDG), developed as a stable analog of a peptide fraction originally isolated from pineal gland tissue extract.
What is telomerase, and why does it come up in Epithalon research?
Telomerase is an enzyme that maintains the repeat sequences at chromosome ends. Khavinson et al. (2003) reported that Epithalon induced telomerase activity and telomere elongation in a cultured human somatic cell line, which is why the peptide is frequently discussed in that specific context.
Has Epithalon been studied in whole-animal models, or only in cultured cells?
Both. In addition to the human cell line work on telomerase, Anisimov et al. (2003) studied Epithalon in a long-term rodent model tracking aging biomarkers, lifespan and spontaneous tumor incidence, and a separate rat study examined its effect on retinal tissue.
What is the proposed mechanism of action?
Researchers in this field propose that Epithalon and related short peptides act at the level of gene transcription, though the 2021 systematic review and 2025 overview cited above both frame this as an area of ongoing mechanistic research rather than a fully settled pathway.
How does Epithalon relate to Pinealon and Thymalin?
All three are short synthetic peptides from the same research program, each modeled on a different tissue extract, pineal for Epithalon and Pinealon and thymic for Thymalin. The comparison is covered in bioregulator peptides explained.
Is Epithalon the same peptide used in every Khavinson bioregulator study?
No. Khavinson's group has characterized a number of distinct short peptides modeled on different tissue extracts. Epithalon and Pinealon are both associated with pineal tissue work, while other family members such as Thymalin are modeled on thymic tissue, so the specific sequence and the specific tissue rationale differ across the family even though the general research approach is shared.
How is Epithalon supplied for laboratory use?
As a lyophilized powder intended for research use only, sold by lot with an accompanying certificate of analysis. See our Epithalon lot page for current specifications.
References
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. PubMed 12937682.
- Khavinson VKh, Bondarev IE, Butyugov AA, et al. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004;137(5):503-506. PubMed 15455129.
- Anisimov VN, Khavinson VKh, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. PubMed 14501183.
- Khavinson VKh, Razumovsky MI, Trofimova SV, et al. Retinoprotective effect of Epithalon in Campbell rats of various ages. Bull Exp Biol Med. 2003;135(5):495-498. PubMed 12910293.
- Khavinson VK, Popovich IG, Linkova NS, et al. Peptide regulation of gene expression: a systematic review. Molecules. 2021;26(22):6979. PubMed 34834147.
- Araj SK, Brzezik J, Mądra-Gackowska K, et al. Overview of Epitalon, highly bioactive pineal tetrapeptide with promising properties. Int J Mol Sci. 2025;26(6):2649. PubMed 40141333.
Research use only. Homegrown Peptides products are for laboratory research and are not for human or animal use. Nothing in this article is medical advice.
